Navigation Links
NFGC Conducts Multi-Institutional Research Project in Ovarian Cancer

$500,000 will be invested in the first phase of this personalized medicine initiative

TAMPA, Fla., April 24 /PRNewswire/ -- The National Functional Genomics Center, funded through an assistance agreement that is awarded and administered by the U.S. Army Medical Research & Materiel Command (USAMRMC) and the Telemedicine & Advanced Technology Research Center (TATRC), will be conducting a multi-institutional collaborative project in ovarian cancer.

For the first phase of the project, the group will use a biologically-driven approach to characterize gene expression and oncogene activation of copy number and point mutations in preclinical models by profiling ovarian cancer cells and ovarian cancer stem cells. The consortium will also characterize platinum resistance and the interaction between ovarian cancer cells and the immune environment.

"There is a huge amount of scientific expertise and knowledge being brought to this project," said Dr. John Parker, Major General, U.S. Army (retired) and NFGC board chair.

The participants who will be sharing data include Jack Pledger, Ph.D., and Johnathan Lancaster, M.D., Ph.D. (Moffitt Cancer Center); Max S. Wicha, M.D., and Weiping Zou, M.D., Ph.D. (University of Michigan Comprehensive Cancer Center and Medical School); Stephen P. Ethier, Ph.D. (Barbara Ann Karmanos Cancer Institute); Ryan Miller, M.D., Ph.D., and Chaoying Yin, Ph.D. (The University of North Carolina at Chapel Hill); Mark D. Carlson, M.D., and Tracy Christianson (Southeast Nebraska Cancer Center); and Tak Sugimura, Ph.D. (Hawaii Institute for Molecular Sciences).

About the National Functional Genomics Center

The NFGC was established to bridge the gap between pure science and patient care and is accelerating applied, translational research by bringing together partners from government, industry, and academia. The NFGC is using this network to develop strategic alliances that will produce benefits that directly apply to the future military healthcare effectiveness and efficiencies, while aggressively advancing the war on cancer - a disease that causes the death of more than half a million Americans a year. NFGC research is discovering molecular signatures of cancer that will allow military and civilian personnel anywhere in the world to be quickly and accurately diagnosed and treated based on each individual's genetic profile.

The mission of the NFGC is to validate the concept that molecular signatures in tumors predict cancer risk, diagnosis, prognosis, and response to therapy, as well as to identify new molecular targets for the development of more effective cancer prevention and personalized therapeutic care.

About H. Lee Moffitt Cancer Center & Research Institute

Located in Tampa, Florida, Moffitt Cancer Center ( is the only Florida-based cancer center with the NCI designation as a Comprehensive Cancer Center for its excellence in research and contributions to clinical trials, prevention and cancer control.

SOURCE H. Lee Moffitt Cancer Center & Research Institute
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. CryoLife Conducts Surgeons Cardiac Allograft Symposium
2. Merck Engages PharmaVentures to Assist in the Divestment of its Italian Research Centre IRBM
3. ULURU to Present Clinical Evidence and Advanced Research on Altrazeal at the Society for Advance Wound Care Conference for 2009
4. Genopole(R) to Accompany 7 Companies and a Research lab to BIO Atlanta
5. Clarient Granted Exclusive License to Commercialize Breast Cancer Biomarker by Indiana University Research and Technology Corporation
6. Akaza Research to Present OpenClinica at ACRP Global Conference & Exhibition
7. Trubion Presents Preclinical Data on Its SCORPION(TM) Multispecific Therapeutics at the 2009 American Association of Cancer Research Annual Meeting
8. Bayer CropScience Donates $1.1 Million to United Fresh Research & Education Foundation to Create the Center for Global Produce Sustainability
9. Setting the Benchmark for Winery Tasting Room Research: An Emerging Region Gets a Global Perspective
10. United States Recognizes Leading Scottish Scientist for Disease Research
11. World BioBank(TM) Launch Benefits Advanced Medical Research
Post Your Comments:
(Date:6/27/2016)... (PRWEB) , ... June 27, 2016 , ... ... to bring innovative medical technologies, services and solutions to the healthcare market. The ... implementation of various distribution, manufacturing, sales and marketing strategies that are necessary to ...
(Date:6/24/2016)... , June 24, 2016 Epic ... sensitively detects cancers susceptible to PARP inhibitors by ... tumor cells (CTCs). The new test has already ... therapeutics in multiple cancer types. Over ... DNA damage response pathways, including PARP, ATM, ATR, ...
(Date:6/23/2016)... June 23, 2016   Boston Biomedical , ... compounds designed to target cancer stemness pathways, announced ... granted Orphan Drug Designation from the U.S. Food ... gastric cancer, including gastroesophageal junction (GEJ) cancer. Napabucasin ... to inhibit cancer stemness pathways by targeting STAT3, ...
(Date:6/23/2016)...  The Prostate Cancer Foundation (PCF) is pleased to announce 24 ... for prostate cancer. Members of the Class of 2016 were selected from a ... Read More About the Class of 2016 PCF Young Investigators ... ... ...
Breaking Biology Technology:
(Date:4/15/2016)... 2016  A new partnership announced today will ... decisions in a fraction of the time it ... high-value life insurance policies to consumers without requiring ... Force Diagnostics, rapid testing (A1C, Cotinine and HIV) ... pressure, weight, pulse, BMI, and activity data) available ...
(Date:4/14/2016)... 14, 2016 BioCatch ™, ... today announced the appointment of Eyal Goldwerger ... Goldwerger,s leadership appointment comes at a time ... the deployment of its platform at several of the ... which discerns unique cognitive and physiological factors, is a ...
(Date:3/31/2016)... , March 31, 2016   ... ("LegacyXChange" or the "Company") LegacyXChange is excited ... of its soon to be launched online site for ... ) will also provide potential shareholders a ... DNA technology to an industry that is notorious for ...
Breaking Biology News(10 mins):